Options
Response rate to the treatment of Waldenström macroglobulinemia: A meta-analysis of the results of clinical trials
Fecha de emisión
2016
Autor(es)
Santos-Lozano A.
Morales-Gonzalez A.
Sanchis-Gomar F.
Cristi-Montero C.
Fiuza-Luces C.
Pareja-Galeano H.
Martínez-López J.
Garatachea N.
Lucia A.
DOI
10.1016/j.critrevonc.2016.06.004
Temas
Meta-analysis
Purine analogues
Rituximab
Waldeström disease
bendamustine
bortezomib
carfilzomib
cladribine
cyclophosphamide
dexamethasone
fludarabine
rituximab
drug combination
cancer combination ch...
drug efficacy
drug response
human
meta analysis
monotherapy
progression free surv...
Review
treatment outcome
Waldenstroem macroglo...
drug combination
Waldenstrom Macroglob...
Drug Combinations
Humans
Treatment Outcome
Waldenstrom Macroglob...
Archivo(s)